Docetaxel (taxotere(R)) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer

By Le Chevalier T.   Monnier A.   Douillard J.Y.   Ruffie P.   Sun X.S.   Belli L.   Ibrahim N.   Bougon N.   Berille J.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2032-2036

Elsevier

Access to resources Recommend Favorite

Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer

By Creane M.   Seymour C. B.   Colucci S.   Mothersill C.  

International Journal of Radiation Biology, Vol. 75, Iss. 6, 1999-06 ,pp. : 731-737

Informa Healthcare

Access to resources Recommend Favorite

Phase II Trials of Docetaxel (Taxotere ( R)) in Advanced Ovarian Cancer--an Updated Overview

By Kaye S.B.   Piccart M.   Aapro M.   Francis P.   Kavanagh J.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2167-2170

Elsevier

Access to resources Recommend Favorite

Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo

By          

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1511-1519

Spandidos Publications

Access to resources Recommend Favorite

Effect of docetaxel (taxotere) on expression of radiation-induced lethal mutations in human cell lines

By Creane M.   Seymour C. B.   Mothersill C.  

International Journal of Radiation Biology, Vol. 75, Iss. 6, 1999-06 ,pp. : 725-730

Informa Healthcare

Access to resources Recommend Favorite